169 related articles for article (PubMed ID: 29076965)
21. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
[TBL] [Abstract][Full Text] [Related]
22. Supervised mutational signatures for obesity and other tissue-specific etiological factors in cancer.
Afsari B; Kuo A; Zhang Y; Li L; Lahouel K; Danilova L; Favorov A; Rosenquist TA; Grollman AP; Kinzler KW; Cope L; Vogelstein B; Tomasetti C
Elife; 2021 Jan; 10():. PubMed ID: 33491650
[TBL] [Abstract][Full Text] [Related]
23. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
[TBL] [Abstract][Full Text] [Related]
24. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
25. Topography of mutational signatures in non-small cell lung cancer: emerging concepts, clinical applications, and limitations.
Jayakrishnan R; Kwiatkowski DJ; Rose MG; Nassar AH
Oncologist; 2024 Jun; ():. PubMed ID: 38907669
[TBL] [Abstract][Full Text] [Related]
26. Environmental and DNA repair risk factors for breast cancer in South China.
Fu XJ; Shi XJ; Lin K; Lin H; Huang WH; Zhang GJ; Au WW
Int J Hyg Environ Health; 2015 May; 218(3):313-8. PubMed ID: 25616561
[TBL] [Abstract][Full Text] [Related]
27. Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-Smokers.
Landi MT; Synnott NC; Rosenbaum J; Zhang T; Zhu B; Shi J; Zhao W; Kebede M; Sang J; Choi J; Mendoza L; Pacheco M; Hicks B; Caporaso NE; Abubakar M; Gordenin DA; Wedge DC; Alexandrov LB; Rothman N; Lan Q; Garcia-Closas M; Chanock SJ
Am J Epidemiol; 2021 Jun; 190(6):962-976. PubMed ID: 33712835
[TBL] [Abstract][Full Text] [Related]
28. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies.
Rustad EH; Nadeu F; Angelopoulos N; Ziccheddu B; Bolli N; Puente XS; Campo E; Landgren O; Maura F
Commun Biol; 2021 Mar; 4(1):424. PubMed ID: 33782531
[TBL] [Abstract][Full Text] [Related]
29. Mutational signatures and mutable motifs in cancer genomes.
Rogozin IB; Pavlov YI; Goncearenco A; De S; Lada AG; Poliakov E; Panchenko AR; Cooper DN
Brief Bioinform; 2018 Nov; 19(6):1085-1101. PubMed ID: 28498882
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic mechanisms and cancer: an interface between the environment and the genome.
Herceg Z; Vaissière T
Epigenetics; 2011 Jul; 6(7):804-19. PubMed ID: 21758002
[TBL] [Abstract][Full Text] [Related]
31. Mutational signatures are markers of drug sensitivity of cancer cells.
Levatić J; Salvadores M; Fuster-Tormo F; Supek F
Nat Commun; 2022 May; 13(1):2926. PubMed ID: 35614096
[TBL] [Abstract][Full Text] [Related]
32. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM.
Barrès R; Zierath JR
Nat Rev Endocrinol; 2016 Aug; 12(8):441-51. PubMed ID: 27312865
[TBL] [Abstract][Full Text] [Related]
33. Mutational Signatures as Sensors of Environmental Exposures: Analysis of Smoking-Induced Lung Tissue Remodeling.
Kim YA; Hodzic E; Amgalan B; Saslafsky A; Wojtowicz D; Przytycka TM
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291592
[TBL] [Abstract][Full Text] [Related]
34. Mutational signatures: emerging concepts, caveats and clinical applications.
Koh G; Degasperi A; Zou X; Momen S; Nik-Zainal S
Nat Rev Cancer; 2021 Oct; 21(10):619-637. PubMed ID: 34316057
[TBL] [Abstract][Full Text] [Related]
35. Mutational signature of aristolochic acid: Clue to the recognition of a global disease.
Rosenquist TA; Grollman AP
DNA Repair (Amst); 2016 Aug; 44():205-211. PubMed ID: 27237586
[TBL] [Abstract][Full Text] [Related]
36. A pooled mutational analysis identifies ionizing radiation-associated mutational signatures conserved between mouse and human malignancies.
Davidson PR; Sherborne AL; Taylor B; Nakamura AO; Nakamura JL
Sci Rep; 2017 Aug; 7(1):7645. PubMed ID: 28794481
[TBL] [Abstract][Full Text] [Related]
37. Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer.
Moore LE; Huang WY; Chung J; Hayes RB
Ann N Y Acad Sci; 2003 Mar; 983():181-96. PubMed ID: 12724223
[TBL] [Abstract][Full Text] [Related]
38. Cancer susceptibility: epigenetic manifestation of environmental exposures.
Weidman JR; Dolinoy DC; Murphy SK; Jirtle RL
Cancer J; 2007; 13(1):9-16. PubMed ID: 17464241
[TBL] [Abstract][Full Text] [Related]
39. Dissecting genetic and environmental mutation signatures with model organisms.
Segovia R; Tam AS; Stirling PC
Trends Genet; 2015 Aug; 31(8):465-74. PubMed ID: 25940384
[TBL] [Abstract][Full Text] [Related]
40. Validating the concept of mutational signatures with isogenic cell models.
Zou X; Owusu M; Harris R; Jackson SP; Loizou JI; Nik-Zainal S
Nat Commun; 2018 May; 9(1):1744. PubMed ID: 29717121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
